Abstract:Objective To investigate the inhibition effects of CpG oligodeoxynucleotide(CpG ODN) on renal carcinoma cell proliferation and tumor growth in vivo and in vitro,and explore the possible mechanism.Methods The effects of different concentrations of CpG ODN1826 and non-CpG ODN1982(ODN1982) interventions on proliferation of human renal clear cell carcinoma cell line Caki-1 cultured in vitro were determined with CCK-8 method.Tumor-bearing nude mouse models were established by subcutaneous implantation of Caki-1 cells into 24 BALB/c mice,and were randomly divided into control group(PBS),ODN1982 group(50 μg ODN1982),low-dose CpG ODN1826 group(25 μg CpG ODN1826) and high-dose CpG ODN1826 group(50 μg CpG ODN1826) 4 d later according to means of weekly treatment,with 6 mice in each group.Mice were sacrificed 35 d after model establishment,and changes of tumor volumes,tumor weight and tumor histology were compared among groups.Splenic lymphocytes of tumor-bearing mice in each group were isolated in vitro,and lactate dehydrogenase release method was employed to detect the cytolytic activity of splenic lymphocytes of tumor-bearing mice to tumor cells with different effector/target ratios(splenic lymphocytes:Caki-1 cells or splenic lymphocytes:YAC-1 cells).Results ODN1982 had no significant effect on in vitro proliferation of Caki-1 cells,while 500 μg/mL CpG ODN1826 significantly inhibited proliferation of Caki-1 cells.The tumor volumes of low-dose CpG ODN1826 group and high-dose CpG ODN1826 group were significantly smaller than those of control group and ODN1982 group at the end point of experiment(P 0.05),and there were significant differences in tumor weight among groups(P 0.05).It was revealed by histological observations that there were more inflammatory cell infiltration in low-dose CpG ODN1826 group and high-dose CpG ODN1826 group.The cytolytic activity of splenic lymphocytes of mice in high-dose CpG ODN1826 group to Caki-1 cells and YAC-1 cells was(9.74 ± 1.16) % and(79.65 ± 5.23) %,respectively at effector/target ratio of 50:1,and was significantly higher than that in control group [(7.67 ± 0.22) % and(10.12 ± 3.03) %,respectively] and ODN1982 group [(7.66 ± 0.93) % and(27.60 ± 9.83) %,respectively](P 0.05).Conclusion CpG ODN can inhibit renal carcinoma cell proliferation in vitro and tumor growth in tumor-bearing nude mice,and the mechanism may relate to the enhancement of innate immunity by CpG ODN.

Enhancing Effect of CpG ODN on Sensitivity of Lewis Lung Cancer to Carboplatin in Mice

CpG-ODN enhances sensitivity to chemotherapy in lung cancer cell line A549

Studies on the Enhancement of DC Vaccine to Mouse Lewis Lung Cancer by CpG Oligonucleotides

The Application of Cytidyl Guanosyl Oligodeoxynucleotide Can Affect the Antitumor Immune Response Induced by a Combined Protocol of Cryoablation and Dendritic Cells in Lewis Lung Cancer Model

The Effect of CpG ODN on Immune Function of Non-Small Cell Lung Cancer Patients after Chemotherapy

Enhancing Radiosensitivity of Human Pulmonary Adenocarcinoma Cell Line A549 by Cpg Odn1826

In Vivo and in Vitro Study of Inhibition Effects of CpG Oligodeoxynucleotide on Renal Carcinoma Cell Proliferation and Tumor Growth

The Study on Angiostatin/cisplatin As Treatment for Lewis Lung Cancer

Targeting Toll-Like Receptor 9 with CpG Oligodeoxynucleotides Enhances Anti-Tumor Responses of Peripheral Blood Mononuclear Cells from Human Lung Cancer Patients.

Effects of CpG Oligodeoxynucleotide 1826 on Transforming Growth Factor-Beta 1 and Radiation-Induced Pulmonary Fibrosis in Mice

The Effect of Carboplatin, on Fractional Dissection Form, Combined with X-ray on the Immune Function of the Lewis Lung Cancer

Effects of CpG Oligodeoxynucleotide 1826 on Acute Radiation-Induced Lung Injury in Mice

Ganoderma Lucidum Polysaccharides Combined with Low-Dose Cisplatin Inhibits Tumor Growth and Enhances the Immune Function of Tumor-Bearing Mice

[Inhibitory effect and the mechanism of Astragalus polysaccharide combined with cisplatin on growth of inplanted Lewis lung carcinoma in mice]

Experimental Study on Improving Radiosensitivity for Lewis Lung Cancer with Gemcitabine

Experimental Research on TMP Combination with DDP in Treating Lewis Lung Carcinoma

Anti-neoplasm and immuno-modification effect of novel CpG oligodeoxynucleotides in mice

Advances in research on the treatment of non-small-cell lung cancer by unmethylated cytidine-phosphate-guanosine-containing oligodeoxynucleotides（CpG ODN）

Immunological effect of CpG ODN1826 on mice of leukemia

Combination of Low-Dose Cisplatin and Recombinant Porcine-Endoglin Induces Synergistic Antitumor Effects in Mice

Effect of 2-[(3-carboxy-1-oxoprogyl) Amino]-2-deoxy-d-glucose on Esophageal Cancer in Nude Mice and Expression of Its Relational Genes